Semaglutide's Effectiveness in Treating Fatty Liver Disease
Semaglutide injections have shown promise in treating fatty liver disease in a clinical trial involving 800 participants, with significant improvements in liver health and weight loss.
Key Points
- Semaglutide injections resulted in improvements in liver enzymes and blood measures of liver fibrosis
- 62.9% of participants had less inflammation and fat accumulation in their livers after treatment
- 36.8% of the semaglutide group saw improvements in liver fibrosis
Pros
- Significant improvements in liver health observed in participants treated with semaglutide
- 10.5% weight loss achieved in participants receiving semaglutide injections
- Promising potential for treating a severe form of liver disease with limited treatment options
Cons
- Some common adverse effects reported in the semaglutide group including nausea, diarrhea, constipation, and vomiting